Posts Tagged: UC Davis

News

UC Davis: First clinical trial of stem cells to treat spina bifida

A stem cell researcher at UC Davis. (Photo: AJ Cheline, UC Davis, via The Stem Cellar)

Backed by $17 million in cash from California’s stem cell agency, researchers at UC Davis this month are launching “the world’s first clinical trial using stem cells to treat spina bifida before the child is born.”

Podcast

Capitol Weekly Podcast: Mindy Romero

Mindy Romero of the Califorrnia Civic Engagement Project. (Photo: Scott Duncan, Capitol Weekly)

Elections expert Mindy Romero of the California Civic Engagement Project joins Capitol Weekly’s John Howard and Tim Foster to chat about California’s primary election turnout and what we might expect to see in November.

News

Stem cell agency: $75 million for diabetes, brain cancer

Stem cell research in what's known as the "PCR strip." (Image: Science Photo, via Shutterstock)

The California stem cell agency yesterday handed out $75 million, doubling down on a couple of efforts to develop a stem cell therapy and a stem cell tool, plus funding an expansion of its Alpha Clinic network with two new, Northern California sites. The awards bring to $2.34 billion that the nearly 13-year-old agency has committed to stem cell research.

Podcast

Capitol Weekly Podcast: Jay Lund

Jay Lund, director of the Center for Watershed Sciences at UC Davis.

The Capitol Weekly Podcast crew crosses the Yolo Causeway to sit down with UC Davis Professor Jay Lund, director of the Center for Watershed Sciences. One of the most respected voices in California water, Lund chats about the evolution of the Central Valley’s water storage and delivery systems. He also takes note of our water infrastructure — including what to watch for as storms and snowmelt pummel the the state.

Podcast

Podcast: UC Davis College Republicans

Andrew Mendoza, left, and Nicholas Francois. (Photo: Tim Foster)

UC Davis College Republicans pulled the plug on a Jan. 13 speaking event featuring far-right firebrand Milo Yiannopoulos and pharmaceutical executive Martin Shkreli after protests against the duo’s appearance overwhelmed campus security.

Support for Capitol Weekly is Provided by: